NO931629L - Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi - Google Patents

Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi

Info

Publication number
NO931629L
NO931629L NO93931629A NO931629A NO931629L NO 931629 L NO931629 L NO 931629L NO 93931629 A NO93931629 A NO 93931629A NO 931629 A NO931629 A NO 931629A NO 931629 L NO931629 L NO 931629L
Authority
NO
Norway
Prior art keywords
plasminogen activator
cleaning
activator inhibitors
immunaffinity
chromatography
Prior art date
Application number
NO93931629A
Other languages
English (en)
Other versions
NO931629D0 (no
Inventor
Johann Hock
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of NO931629D0 publication Critical patent/NO931629D0/no
Publication of NO931629L publication Critical patent/NO931629L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/10—Packet switching elements characterised by the switching fabric construction
    • H04L49/102—Packet switching elements characterised by the switching fabric construction using shared medium, e.g. bus or ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/10—Packet switching elements characterised by the switching fabric construction
    • H04L49/103—Packet switching elements characterised by the switching fabric construction using a shared central buffer; using a shared memory
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/30—Peripheral units, e.g. input or output ports
    • H04L49/3027—Output queuing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Fremgangsmåte for immunaffinltetskromatografisk rensing av plasminogen-aktivator-hemmer 2 (PAI-2) og monoklonale antistoffer, som er egnet for en slik fremgangsmåte.
NO93931629A 1992-05-06 1993-05-05 Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi NO931629L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4214999A DE4214999C2 (de) 1992-05-06 1992-05-06 Reinigung von Plasminogen-Aktivator-Inhibitor 2 durch Immunaffinitätschromatographie

Publications (2)

Publication Number Publication Date
NO931629D0 NO931629D0 (no) 1993-05-05
NO931629L true NO931629L (no) 1993-11-08

Family

ID=6458317

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931629A NO931629L (no) 1992-05-06 1993-05-05 Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi

Country Status (12)

Country Link
US (1) US5362857A (no)
EP (1) EP0568836A1 (no)
JP (1) JPH069695A (no)
KR (2) KR930024353A (no)
AU (1) AU3837193A (no)
CA (1) CA2095577A1 (no)
DE (1) DE4214999C2 (no)
IL (1) IL105610A0 (no)
MX (1) MX9302629A (no)
NO (1) NO931629L (no)
NZ (1) NZ247533A (no)
ZA (1) ZA932443B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049887A1 (en) 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134065A (en) * 1986-05-16 1992-07-28 Monsanto Company Tissue plasminogen activator inhibitor and method of purification
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
US5204256A (en) * 1989-09-06 1993-04-20 Behringwerke Aktiengesellschaft Process for the purification of plasminogen activator inhibitor 2 (pai-2)
ES2106772T3 (es) * 1989-12-20 1997-11-16 Biotech Australia Pty Ltd Variantes de pai-2.

Also Published As

Publication number Publication date
MX9302629A (es) 1993-11-01
EP0568836A1 (de) 1993-11-10
KR930024353A (ko) 1993-12-22
IL105610A0 (en) 1993-09-22
DE4214999C2 (de) 1994-07-14
JPH069695A (ja) 1994-01-18
US5362857A (en) 1994-11-08
NO931629D0 (no) 1993-05-05
ZA932443B (en) 1993-10-20
KR940005284A (ko) 1994-03-21
AU3837193A (en) 1993-11-11
DE4214999A1 (de) 1993-11-11
NZ247533A (en) 1994-12-22
CA2095577A1 (en) 1993-11-07

Similar Documents

Publication Publication Date Title
EA199700087A1 (ru) Способ ингибирования катепсина к
DE69516866T2 (de) Stereochemische wortmanninderivate
DE69229393D1 (de) Verfahren zur reinigung von hmg-coa reductase-inhibitoren
DK0627002T3 (da) Kloning og ekspression af humaniserede monoklonale antistoffer mod human interleukin-4
NO932620L (no) Amindiol-proteaseinhibitorer
NO952494L (no) Nytt protein fra urin med betegnelse komponent B
ATE222761T1 (de) Tetrahydrofuranyl (thf) enthaltende sulfonamidinhibitoren der aspartyl-protease
NO990548D0 (no) Inhibitorer for cystein-protease
DE3574014D1 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
EP0820287A4 (en) THROMBIN INHIBITORS
NO944430L (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
DK0659702T3 (da) Fremgangsmåde til cementering af en underjordisk zone
DE69502378T2 (de) Metalloproteinaseinhibitoren
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
DE69413167D1 (de) Peptid-Phosphinyloxymethyl-Ketonen als Inhibitoren von Interleukin-1 beta-konvertierenden Enzymen
NO981520D0 (no) Tiosubstituerte peptider som inhibitorer for metalloproteinaser og TNF-frigjöring
EA199800200A1 (ru) Ингибиторы пролилэндопептидазы
NO931629L (no) Rensing av plasminogen-aktivator-hemmer 2 ved immunaffinitetskromatografi
AU6144686A (en) Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for purification, removal, inhibition or assay of the inhibitors
DK0623614T3 (da) 4-aryl-4-hydroxy-tetrahydropyraner og 3-aryl-3-hydroxy-tetrahydrofuraner som inhibitorer for 5-lipoxygenase
FI953002A0 (fi) Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
KR960702752A (ko) 생물학적 제제를 연속적으로 적용시키는 붕대(bandage for continuous application of biologicals)
FR2694208B1 (fr) Procédé et dispositif industriels de fractionnement de mélanges de composants par chromatographie.
ZA969078B (en) Inhibitors of cysteine protease.